Nicolai Buhl Andersen
Corporate Officer/Principal bei COLOPLAST A/S
Ursprung des Netzwerks ersten Grades von Nicolai Buhl Andersen
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Medical Specialties | 18 | |
| Public Company | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nicolai Buhl Andersen
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Chairman | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DEMANT A/S | Medical Specialties | Director/Board Member Director/Board Member | |
| UDG HEALTHCARE PLC | Miscellaneous Commercial Services | Director/Board Member | |
| MT HØJGAARD HOLDING A/S | Homebuilding | Director/Board Member | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer | |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer President | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Executive Officer Director/Board Member | |
DADES A/S
 DADES A/S Real Estate DevelopmentFinance DADES A/S provides real estate investment services. It owns and operates shopping centers, office buildings, and residential properties. The company was founded by Ejnar Danielsen in 1937 and is headquartered in Kongens Lyngby, Denmark. | Real Estate Development | Director/Board Member Chairman | |
| Copenhagen Business School | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| University of Lancaster | College/University | Graduate Degree Graduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Corporate Officer/Principal Director/Board Member | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Technical University of Denmark | College/University | Chairman Graduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| University of Lund | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Director/Board Member Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| University of Utrecht | College/University | Doctorate Degree | |
| Scandinavian International Management Institute | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
HTL-STREFA SA
 HTL-STREFA SA Medical SpecialtiesHealth Technology HTL-STREFA SA manufactures and sells medical devices. Its offer lancets, needles and lancing devices for collection of capillary blood and blood glucose monitoring. The company was founded in 2000 and is headquartered in Ozorków, Poland. | Medical Specialties | Chairman | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal President Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Molecular Biology Consultants | Director/Board Member | ||
| MERUS N.V. | Biotechnology | Director/Board Member Chairman | |
| Novo Nordisk North America, Inc. | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal | ||
Coloplast Corp.
 Coloplast Corp. Medical DistributorsDistribution Services Coloplast Corp. develops medical devices. The firm offers continence care, ostomy care, wound care, bladder and bowel, and skin care products. The company was founded in 1978 and is headquartered in Minneapolis, MN. | Medical Distributors | Chief Executive Officer Chief Executive Officer | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
Teva Pharmaceuticals Europe BV
 Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The company is based in Haarlem, Netherlands. | Miscellaneous | Chief Executive Officer | |
| Astra Hässle AB | Director/Board Member | ||
| Glaxowellcom | Corporate Officer/Principal | ||
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Director of Finance/CFO Chief Executive Officer | |
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Nordisk Film TV-Produktion AB
 Nordisk Film TV-Produktion AB Movies/EntertainmentConsumer Services Nordisk Film TV-Produktion AB produces television series and films. It offers reality and game shows, children movies, and other show genres. The company was founded in 1997 and is headquartered in Stockholm, Sweden. | Movies/Entertainment | Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Corporate Officer/Principal | |
Centre for Human Drug Research
 Centre for Human Drug Research BiotechnologyHealth Technology The Centre for Human Drug Research provides clinical drug research services. The private company is based in Leiden, Netherlands. Adam F. Cohen has been the CEO of the Dutch company since 1987. | Biotechnology | Director/Board Member | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Curaeos BV
 Curaeos BV Medical/Nursing ServicesHealth Services Curaeos BV operates as a holding company with interests in dentistry business. It offers both general and specialist dental care products and services. The firm is known for brands like DentConnect and DentalCoop. The company was founded by Jim Vermeule and is headquartered in Oosterhout, the Netherlands. | Medical/Nursing Services | Chairman | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director of Finance/CFO Chairman Director/Board Member Corporate Officer/Principal | |
| Hubrecht Organoid Technology Foundation | Chairman | ||
Coloplast GmbH
 Coloplast GmbH Medical DistributorsDistribution Services Part of Coloplast A/S, Coloplast GmbH is a wholesaler of pharmaceutical, medical, and orthopedic products. The company is based in Hamburg, Germany. The CEOs are Henning Reichardt, Kristian Villumsen. The German company was founded in 1957. | Medical Distributors | Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Chairman | |
Alvogen Lux Holdings SARL
 Alvogen Lux Holdings SARL Pharmaceuticals: GenericHealth Technology Part of Celtic Holdings SCA, Alvogen Lux Holdings SARL is a Luxembourger company that manufactures generic pharmaceutical products. The company is based in Nidderaanwen, Luxembourg. The CEO of the company is Vilhelm Róbert Wessman. | Pharmaceuticals: Generic | Director/Board Member |
Statistik
International
| Dänemark | 22 |
| Vereinigte Staaten | 9 |
| Niederlande | 8 |
| Schweden | 5 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 10 |
| Finance | 5 |
| Miscellaneous | 4 |
| Health Services | 3 |
Operativ
| Director/Board Member | 238 |
| Chairman | 85 |
| Corporate Officer/Principal | 82 |
| Independent Dir/Board Member | 50 |
| Chief Executive Officer | 47 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Jack Nielsen | 38 |
| Ole Larsen | 32 |
| Sten Scheibye | 31 |
| Claus Tycho Bræstrup | 27 |
| Anna Héléne Barnekow | 24 |
| Marianne Wiinholt | 22 |
| Carsten Hellmann | 22 |
| Peter Helt Jacobsen Haahr | 21 |
| Lars Søren Rasmussen | 21 |
| Terje Kalland | 20 |
| Jette Nygaard-Andersen | 18 |
| Marianne Kock | 16 |
| Gerardus Wilhelmus van Odijk | 16 |
| Carsten Boess | 15 |
- Börse
- Insiders
- Nicolai Buhl Andersen
- Unternehmensverbindungen
